These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29914539)

  • 1. Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.
    Zhang R; Zhang TT; Zhai GQ; Guo XY; Qin Y; Gan TQ; Zhang Y; Chen G; Mo WJ; Feng ZB
    World J Surg Oncol; 2018 Jun; 16(1):109. PubMed ID: 29914539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation.
    Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G
    World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of HOXA13 as a potential tumorigenesis and progression promoter of LUSC based on qRT-PCR and bioinformatics.
    Zhang R; Deng Y; Zhang Y; Zhai GQ; He RQ; Hu XH; Wei DM; Feng ZB; Chen G
    Int J Clin Exp Pathol; 2017; 10(10):10650-10665. PubMed ID: 31966409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
    Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of downregulation and prospective pathway signaling of microRNA-375 in lung squamous cell carcinoma.
    Chen WJ; Gan TQ; Qin H; Huang SN; Yang LH; Fang YY; Li ZY; Pan LJ; Chen G
    Pathol Res Pract; 2017 Apr; 213(4):364-372. PubMed ID: 28214218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
    Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
    Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Role and Regulation Mechanism of hsa-miR-147b in Lung Squamous Cell Carcinoma Based on The Cancer Genome Atlas Database.
    Ke D; Guo Q; Fan TY; Xiao X
    Cancer Biother Radiopharm; 2021 Apr; 36(3):280-291. PubMed ID: 33112657
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of high expression profiles of miR-31-5p and its vital role in lung squamous cell carcinoma: a survey based on qRT-PCR and bioinformatics analysis.
    Chi XJ; Wei LL; Bu Q; Mo N; Chen XY; Lan D; Zhou QN
    Transl Cancer Res; 2019 Jun; 8(3):788-801. PubMed ID: 35116817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells.
    Zhang Y; He RQ; Dang YW; Zhang XL; Wang X; Huang SN; Huang WT; Jiang MT; Gan XN; Xie Y; Li P; Luo DZ; Chen G; Gan TQ
    Cancer Cell Int; 2016; 16():89. PubMed ID: 27980454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation.
    Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G
    Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of HOXA1 promotes tumorigenesis and development of non‑small cell lung cancer: A comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis.
    Zhang Y; Li XJ; He RQ; Wang X; Zhang TT; Qin Y; Zhang R; Deng Y; Wang HL; Luo DZ; Chen G
    Int J Oncol; 2018 Jul; 53(1):73-86. PubMed ID: 29658571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression level and clinical significance of LncRNA HOXA11-AS in esophageal squamous cell carcinoma patients].
    Sun XY; Wang XF; Cui YB; Cao XG; Zhao RH; Wei HY; Cao W; Wu W
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):186-190. PubMed ID: 29575836
    [No Abstract]   [Full Text] [Related]  

  • 15. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
    Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
    Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma.
    Wang XM; Chen SW; Chen G; Zhou HF; Gan TQ; Zeng JJ; Li ZY
    Anal Cell Pathol (Amst); 2021; 2021():6614331. PubMed ID: 34888137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data.
    Sun F; Yang X; Jin Y; Chen L; Wang L; Shi M; Zhan C; Shi Y; Wang Q
    Mol Med Rep; 2017 Jul; 16(1):609-616. PubMed ID: 28560415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exostosin1 as a novel prognostic and predictive biomarker for squamous cell lung carcinoma: A study based on bioinformatics analysis.
    Wu D; Huo C; Jiang S; Huang Y; Fang X; Liu J; Yang M; Ren J; Xu B; Liu Y
    Cancer Med; 2021 Apr; 10(8):2787-2801. PubMed ID: 33314711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple mutations of lung squamous cell carcinoma shared common mechanisms.
    Li Q; Hou J; Hu Z; Gu B; Shi Y
    Oncotarget; 2016 Nov; 7(48):79629-79636. PubMed ID: 27835590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.